<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-09-28T00:12:43Z</responseDate><request verb="GetRecord" identifier="oai:riubu.ubu.es:10259/12129" metadataPrefix="mods">https://riubu.ubu.es/oai/request</request><GetRecord><record><header><identifier>oai:riubu.ubu.es:10259/12129</identifier><datestamp>2026-09-24T00:05:37Z</datestamp><setSpec>com_10259_11209</setSpec><setSpec>com_10259_5086</setSpec><setSpec>com_10259_2604</setSpec><setSpec>col_10259_11210</setSpec></header><metadata><mods:mods xmlns:mods="http://www.loc.gov/mods/v3" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
<mods:name>
<mods:namePart>Viribay, Aitor</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Alcantara, Juan M. A.</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>López, Iker</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Mielgo Ayuso, Juan</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Castañeda Babarro, Arkaitz</mods:namePart>
</mods:name>
<mods:extension>
<mods:dateAvailable encoding="iso8601">2026-09-23T08:47:12Z</mods:dateAvailable>
</mods:extension>
<mods:extension>
<mods:dateAccessioned encoding="iso8601">2026-09-23T08:47:12Z</mods:dateAccessioned>
</mods:extension>
<mods:originInfo>
<mods:dateIssued encoding="iso8601">2024-02</mods:dateIssued>
</mods:originInfo>
<mods:identifier type="issn">1439-6319</mods:identifier>
<mods:identifier type="uri">https://hdl.handle.net/10259/12129</mods:identifier>
<mods:identifier type="doi">10.1007/S00421-024-05415-4</mods:identifier>
<mods:identifier type="essn">1439-6327</mods:identifier>
<mods:abstract>Purpose Citrulline (CIT) and beetroot extract (BR) have separately shown benefits in rowing performance-related outcomes.&#xd;
However, effects of combined supplementation remain to be elucidated. The main purpose of this research was to study the&#xd;
effects of 1 week of daily co-supplementation of 3.5 g BR (500 mg NO3&#xd;
−) plus 6 g CIT on aerobic performance, maximal&#xd;
strength, and high-intensity power and peak stroke in elite male rowers compared to a placebo and to a BR supplementation.&#xd;
Methods 20 elite rowers participated in this randomized, double-blind, placebo-controlled crossover trial completing 1 week&#xd;
of supplementation in each group of study: Placebo group (PLAG); BR group (BRG); and BR + CIT group (BR-CITG).&#xd;
3 main physical tests were performed: aerobic performance, Wingate test and CMJ jump, and metabolic biomarkers and&#xd;
physiological outcomes were collected.&#xd;
Results The Wingate all-out test showed no between-condition differences in peak power, mean power, relative power, or&#xd;
fatigue index (P > 0.05), but clearance of lactate was better in BR-CITG (P &lt; 0.05). In the performance test, peak power&#xd;
differed only between PLAG and BR-CITG (P = 0.036), while VO2peak and maximum heart rate remained similar. CMJ&#xd;
jumping test results showed no between-condition differences, and blood samples were consistent (P > 0.200).&#xd;
Conclusion Supplementation with 3.5 g of BR extract plus 6 g of CIT for 7 days improved lactate clearance after Wingate&#xd;
test and peak power in a performance test. No further improvements were found, suggesting longer period of supplementation&#xd;
might be needed to show greater benefits.</mods:abstract>
<mods:language>
<mods:languageTerm>eng</mods:languageTerm>
</mods:language>
<mods:accessCondition type="useAndReproduction">http://creativecommons.org/licenses/by/4.0/</mods:accessCondition>
<mods:accessCondition type="useAndReproduction">info:eu-repo/semantics/openAccess</mods:accessCondition>
<mods:accessCondition type="useAndReproduction">Atribución 4.0 Internacional</mods:accessCondition>
<mods:subject>
<mods:topic>Physiology</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Oxide nitric</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Supplementation</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Metabolism</mods:topic>
</mods:subject>
<mods:titleInfo>
<mods:title>Impact of a short-term nitrate and citrulline co-supplementation on sport performance in elite rowers: a randomized, double-blind, placebo-controlled crossover trial</mods:title>
</mods:titleInfo>
<mods:genre>info:eu-repo/semantics/article</mods:genre>
</mods:mods></metadata></record></GetRecord></OAI-PMH>